Lead Scientist, Mid/Large-Scale Oligonucleotide Synthesis

Novartis

Basel

Vor Ort

CHF 93.800 - 174.200

Vollzeit

14 Tage+

Erhalte mehr Antworten von Arbeitgebern

Versende in nur wenigen Minuten einen passgenauen Lebenslauf.

Benefits dieser Stelle

Flexible and hybrid working options
Minimum 14 weeks paid parental leave
Insurance plans
Retirement plans
Wellbeing resources
Global recognition programs

Zusammenfassung

Novartis xRNA Therapeutics in Basel seeks a PhD-level scientist to lead mid/large-scale oligonucleotide synthesis and manage a team at our Basel site. The role requires collaboration across research and development to advance RNA therapies addressing unmet medical needs.

You will mentor scientists in synthesis, purification, and conjugation, collaborate with global teams, and drive process development and scale-up for oligonucleotide modalities supporting in vivo studies.

Qualifikationen

  • Ph.D. in Chemistry or related discipline with a strong focus on oligonucleotide chemistry and synthesis.
  • Minimum 2–3 years of industry experience in mid- to large-scale oligonucleotide solid-phase synthesis, purification, analysis, conjugation.
  • Extensive experience operating and maintaining AKTA Oligopilot/Oligosynt systems and AKTA Avant purification platforms; proficiency in Unicorn software.
  • Strong hands-on experience with process development, method optimization and scale-up strategies of oligonucleotides.
  • Demonstrated leadership, including mentoring and team management.
  • Strong communication skills and ability to work effectively in a matrixed cross-functional global teams' environment.

Aufgaben

  • Plan and execute medium- and large-scale solid-phase synthesis, purification, and analysis of chemically modified oligonucleotides and conjugates.
  • Mentor and lead a team of scientists specialized in oligonucleotide synthesis, purification, analysis, and conjugation at millimole scale.
  • Collaborate with global discovery, development, and project teams to advance novel oligonucleotide chemistries and enable transition to development.
  • Identify and implement technologies and workflows to enhance production capabilities and turn-around times.
  • Communicate scientific findings and project updates to stakeholders via presentations and reports.
  • Maintain high-quality scientific documentation including ELNs, protocols, and project summaries.
  • Foster a culture of scientific excellence, collaboration, and problem solving.

Kenntnisse

Oligonucleotide synthesis
AKTA Oligopilot
AKTA Avant
Unicorn software
Leadership
Mentoring
Cross-functional collaboration
Process development
Scale-up
Communication skills

Ausbildung

PhD in Chemistry or related field

Tools

Unicorn software
AKTA Oligopilot
AKTA Avant purification platforms

Jobbeschreibung

Novartis xRNA Therapeutics in Basel seeks a PhD-level scientist to lead mid/large-scale oligonucleotide synthesis and manage a team at our Basel site. The role requires collaboration across research and development to advance RNA therapies addressing unmet medical needs.

You will mentor scientists in synthesis, purification, and conjugation, collaborate with global teams, and drive process development and scale-up for oligonucleotide modalities supporting in vivo studies.

Hol dir deinen kostenlosen, vertraulichen Lebenslauf-Check.
oder ziehe deine Datei hierhin.
Similar jobs

Ähnliche Jobs, die dir auch gefallen könnten

Principal Scientist - Mid/Large Scale Oligonucleotide Synthesis, xRNA Therapeutics
Principal Scientist - Mid/Large Scale Oligonucleotide Synthesis, xRNA Therapeutics

Novartis • Basel

Vor Ort
CHF 93.800 - 174.200
Flexible and hybrid working options
Minimum 14 weeks paid parental leave
Insurance plans
+3
Director, Oligonucleotide Commercial Growth
Director, Oligonucleotide Commercial Growth

Lonza Group Ltd. • Basel

Vor Ort
Confidential
Agile culture
Inclusive workplace
Performance-based compensation
+1
Director of Oligonucleotide Commercial Growth & Strategy
Director of Oligonucleotide Commercial Growth & Strategy

Lonza • Basel

Hybrid
Confidential
Agile culture
Inclusive workplace
Competitive compensation
+1
Director, Commercial Development Oligonucleotides
Director, Commercial Development Oligonucleotides

Lonza • Basel

Vor Ort
Confidential
Agile culture
Inclusive workplace
Competitive compensation
+1
Director, Commercial Development Oligonucleotides
Director, Commercial Development Oligonucleotides

Lonza • Schweiz

Vor Ort
Confidential
Dynamic working culture
Inclusive workplace
Competitive compensation programs
+1
Senior Proteomics Lab Leader, Translational Discovery
Senior Proteomics Lab Leader, Translational Discovery

Novartis Farmacéutica • Basel-Stadt

Vor Ort
CHF 126.000 - 234.000
Hybrid work options
Parental leave 14 weeks
Competitive benefits
Principal Scientist, siRNA Design & AI-Driven Therapeutics
Principal Scientist, siRNA Design & AI-Driven Therapeutics

F. Hoffmann-La Roche AG • Basel

Vor Ort
CHF 100.000 - 130.000
Automation-Driven Synthesis Scientist
Automation-Driven Synthesis Scientist

F. Hoffmann-La Roche AG • Basel

Vor Ort
CHF 120.000 - 180.000
Internship in Oligonucleotide Synthesis (as of September for 12 months - 3 openings in Basel)
Internship in Oligonucleotide Synthesis (as of September for 12 months - 3 openings in Basel)

3M HEALTHCARE • Basel

Vor Ort
CHF 17.000 - 23.000
Director, Commercial Development Oligonucleotides
Director, Commercial Development Oligonucleotides

Lonza Group Ltd. • Basel

Vor Ort
Confidential
Agile culture
Inclusive workplace
Performance-based compensation
+1